Skip to main content
Livermore
Livermore
ZHEN

Esperion Therapeutics, Inc.

ESPRDelisted Jul 13, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001434868

Esperion Therapeutics, Inc. was delisted on Jul 13, 2026; its insiders filed their last Form 4 on Jul 13, 2026; 191 institutions reported holding it in 13F filings for Q2 2026, worth $646.8M in total; Soros Fund Management was the only superinvestor holding it.

Q4 2021 vs. Q3 2021

How the institutions holding Esperion Therapeutics, Inc. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of ESPR: Q3 2021 compared with Q4 2021
MeasureQ3 2021Of which not filed for Q4 2021Q4 2021Change
Holders1391133−5
Shares24.8M126.0K53.6M+28.9M (+116.9%)
Value$299.4M$1.52M$268.0M−$29.8M (−10.0%)

1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (44)

Institutions that held Esperion Therapeutics, Inc. at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to ESPR in Q4 2021
InstitutionSharesValue% of portfolio
Deep Track Capital, LP5,641,668$28.2M2.08%
Deerfield Management Company, L.P. (Series C)5,000,000$25.0M0.53%
Altium Capital Management LP2,515,785$12.6M3.53%
CVI Holdings, LLC1,460,595$7.30M0.48%
Sabby Management, LLC940,400$4.70M1.17%
Paradigm Biocapital Advisors LP839,257$4.20M1.20%
Monaco Asset Management SAM500,000$2.50M1.56%
Pentwater Capital Management LP362,580$1.81M0.03%
Highbridge Capital Management LLC345,595$1.73M0.04%
Two Sigma Investments, LP342,647$1.71M0.00%
Wellington Management Group LLP218,320$1.09M0.00%
Tenor Capital Management Co., L.P.185,838$929.0K0.02%
Walleye Capital LLC160,749$804.0K0.03%
Alyeska Investment Group, L.P.142,857$714.0K0.01%
Ensign Peak Advisors, Inc133,150$666.0K0.00%
Ameriprise Financial Inc112,644$564.0K0.00%
Polar Asset Management Partners Inc.105,551$528.0K0.01%
Occudo Quantitative Strategies LP51,072$255.0K0.02%
Telemetry Investments, L.L.C.50,500$252.0K0.33%
Sculptor Capital LP46,500$233.0K0.00%
Rafferty Asset Management, LLC34,327$172.0K0.00%
Kestra Advisory Services, LLC32,700$164.0K0.00%
Parallax Volatility Advisers, L.P.28,178$141.0K0.00%
Manteio Capital LLC24,074$120.0K0.15%
NinePointTwo Capital22,403$112.0K0.04%
Arrowstreet Capital, Limited Partnership19,324$97.0K0.00%
Alpine Global Management, LLC19,082$95.0K0.01%
Dynamic Technology Lab Private Ltd16,570$83.0K0.01%
National Bank of Canada12,309$61.0K0.00%
Paloma Partners Management Co11,225$56.0K0.00%
Spire Wealth Management10,114$51.0K0.00%
ProShare Advisors LLC10,015$50.0K0.00%
Aquatic Capital Management LLC3,500$18.0K0.03%
Ahrens Investment Partners LLC2,000$10.0K0.00%
NewSquare Capital LLC1,600$8.00K0.00%
Trust Co of Vermont300$2.00K0.00%
Howe & Rusling Inc100$1.00K0.00%
Glassman Wealth Services270$1.00K0.00%
Quadrant Capital Group LLC107$1.00K0.00%
Snowden Capital Advisors LLC200$1.00K0.00%
City State Bank200$1.00K0.00%
AdvisorNet Financial, Inc95$00.00%
CWM, LLC50$00.00%
Lenox Wealth Advisors, LLC68$00.00%

Sold out (49)

Institutions that held Esperion Therapeutics, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of ESPR in Q4 2021
InstitutionShares, Q3 2021Value, Q3 2021
Marshall Wace, LLP520,095$6.27M
Granahan Investment Management Inc293,766$3.54M
Linden Advisors LP116,827$1.41M
Cinctive Capital Management LP110,558$1.33M
Russell Investments Group, Ltd.94,505$1.14M
Swiss National Bank52,400$631.0K
Maverick Capital LtdSuperinvestorMaverick Capital49,973$602.0K
Virginia Retirement Systems Et Al48,800$588.0K
Ergoteles LLC48,200$581.0K
Jacob Asset Management of New York LLC47,534$573.0K
Duality Advisers, LP42,213$509.0K
Susquehanna International Group, LLP41,597$501.0K
State of Wisconsin Investment Board34,800$419.0K
Alps Advisors Inc34,653$418.0K
UBS Asset Management Americas Inc33,476$403.4K
Nomura Holdings Inc31,045$369.0K
Jump Financial, LLC27,000$326.0K
Simplex Trading, LLC14,802$316.0K
Gsa Capital Partners LLP23,628$285.0K
Price T Rowe Associates Inc22,522$271.0K
M&G Investment Management Ltd21,273$255.0K
EMC Capital Management27,566$246.0K
Virtus ETF Advisers LLC17,773$214.0K
Group One Trading, L.P.15,754$190.0K
Man Group plc15,756$190.0K
Pinz Capital Management, LP15,300$184.0K
Allianz Asset Management GmbH15,205$183.0K
Centiva Capital, LP15,038$182.0K
Invesco Ltd.12,667$153.0K
Voya Investment Management LLC10,593$128.0K
DekaBank Deutsche Girozentrale10,000$123.0K
International Biotechnology Trust PLC9,500$114.0K
Metropolitan Life Insurance Co7,777$93.7K
MetLife Investment Management5,894$71.0K
Zurcher Kantonalbank (Zurich Cantonalbank)2,941$35.0K
Antonetti Capital Management LLC2,100$25.0K
Great West Life Assurance Co1,660$20.0K
Point72 Hong Kong Ltd1,644$20.0K
Gilder Gagnon Howe & Co LLC1,006$12.0K
Macquarie Group Ltd976$12.0K
Penserra Capital Management LLC645$7.00K
Dark Forest Capital Management LP596$7.00K
Nisa Investment Advisors, LLC405$5.00K
TCI Wealth Advisors, Inc.303$4.00K
Jacobi Capital Management LLC200$2.00K
Glen Eagle Advisors, LLC110$1.33K
Fifth Third Bancorp50$1.00K
North Star Investment Management Corp.100$1.00K
McCarthy Asset Management, Inc.100$1.00K

Not filed for Q4 2021 yet (1)

Institutions that held Esperion Therapeutics, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ESPR in Q3 2021 that haven't filed for Q4 2021
InstitutionShares, Q3 2021Value, Q3 2021
Marshall Wace North America L.P.125,953$1.52M